個股熱度排行 | 3月7日港股盤前
根據uSMART輿情監測數據，週末期間，市場關注指數最高的5只股票是騰訊控股、凱萊英、比亞迪股份、綠葉製藥、融創中國。
3月7日—港股關注排行TOP5
騰訊控股
關注度第一爲騰訊控股，該股上個交易日收盤下跌3.72%，報於403.20港元。近5個交易日累計下跌4.91%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
騰訊馬化騰倡引導技術資金等流向實體 應向核心產業進行研發
珍惜400港元的騰訊？段永平不孤單，海外第三、第四大中國股票基金“抄底”來了
凱萊英
關注度第二爲凱萊英，該股上個交易日收盤下跌1.57%，報於251.00港元。近5個交易日累計下跌8.06%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
凱萊英：擬投資30億元在上海奉賢建生物藥CDMO研發及商業化生產基地
凱萊英擬投30億元在上海建設生物藥CDMO研發及商業化生產基地
比亞迪股份
關注度第三爲比亞迪股份，該股上個交易日收盤下跌8.61%，報於212.40港元。近5個交易日累計下跌10.00%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
中信證券：比亞迪股份2月銷量超預期 跑贏行業凸顯強車型週期
比亞迪變陣 “蔚小理”接招
綠葉製藥
關注度第四爲綠葉製藥，該股上個交易日收盤下跌1.25%，報於3.15港元。近5個交易日累計下跌1.56%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
綠葉製藥在香港提交Lurbinectedin新藥上市申請；遠洋服務預期2021年淨利同比增加不低於65%
綠葉製藥在中國香港提交Lurbinectedin新藥上市申請，有望加速惠及粵港澳大灣區患者
融創中國
關注度第五爲融創中國，該股上個交易日收盤下跌7.15%，報於6.36港元。近5個交易日累計下跌16.86%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
鄭煤機2021年歸母淨利同比增54.59%至19.16億元 融創中國2月合同銷售額約223.6億元
融創中國2月合同銷售金額約223.6億元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
